News|Articles|May 20, 2026

Q&A: Improving Generics Access in Hospitals

Rahul Mittal shows how execution infrastructure can improve access, cut delays, and strengthen coordination for generic drug manufacturers in hospitals.

The US hospital generics market continues to face a difficult contradiction: manufacturers, distributors, and health systems have access to more data than ever, yet drug shortages persist and access remains uneven, particularly for smaller and lower tier hospitals.

Related to this article

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | © Tada Images - stock.adobe.com 521699065
In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.